National Institute of Allergy and Infectious Diseases
National Institutes of Health

Search
	Advanced Search

Help | Site Index | Contact Us

Tuberculosis (TB)

What are TB, MDR TB, and XDR TB?

Definitions of Tuberculosis, Multidrug-Resistant TB (MDR TB) and Extensively Drug-Resistant TB (XDR TB)

Click to View Drug-Resistant TB — A Visual Tour, illustration
View Drug-Resistant TB — A Visual Tour

Understanding TB

History of TB
Causes
Transmission
Symptoms
Diagnosis
Treatment
Prevention
TB and HIV
Publications

The New Challenge for TB Research

An ancient disease, TB remains one of the major causes of disability and death worldwide. In 2006, 9.2 million new cases of TB emerged and TB killed 1.7 million people. NIAID is examining TB at its fundamental levels through research aimed at developing faster diagnostic tools, better vaccines, and shorter treatment times.

Multidrug-resistant and Extensively Drug-resistant Tuberculosis Research Agenda (PDF)

NIAID’s Role in Addressing Tuberculosis (TB), Drug-Resistant TB, and TB in People with HIV/AIDS

	TB Research at NIAID

	Research Goals Basic Research Diagnostic Research Advances in Treatment Prevention: Vaccine Development Global Research Scientific Illustrations of Drug-Resistant TB	NIAID Labs Networks, Consortia and Partners Resources Training Meetings Scientific Literature